<div id="readability-page-1">07:44 AM EST, 11/17/2025 (MT Newswires) -- COSCIENS Biopharma ( CSCIF ) , which rose 3.15% on Friday, announced over the weekend that the chairman of its board of directors, Peter H. Puccetti, has been appointed as the company's interim chief executive, effective immediately.Puccetti expands his role with this appointment and succeeds Anna Biehn, who has stepped down as CEO.Shares of the company were last seen up $0.1 to $3.3 on Friday on the Toronto Stock Exchange. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

CSCI

CSCIF

美國東部時間 2025 年 11 月 17 日早上 7:44（MT Newswires）-- COSCIENS Biopharma（CSCIF）在週五上漲了 3.15%，並在週末宣佈其董事會主席 Peter H. Puccetti 已被任命為公司的臨時首席執行官，立即生效。Puccetti 在此次任命中擴展了他的角色，接替已辭去首席執行官職務的 Anna Biehn。該公司股票在多倫多證券交易所的最新交易價格為上漲 0.1 美元，至 3.3 美元。MT Newswires 不提供投資建議。未經授權的複製是嚴格禁止的

COSCIENS Biopharma 任命 Peter H. Puccetti 為臨時首席執行官